Frank Clyburn
CIK: 0001763963
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 18, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct1.2K shares- - Apr 16, 2026KLRA
Kailera Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
38.3K shares- - Mar 5, 2026COR
Cencora, Inc.
Award(A)Direct557 shares at avg. $359.28$200K - Jun 26, 2025RVMD
Revolution Medicines, Inc.
Award(A)Direct2.8K shares- - Mar 11, 2025COR
Cencora, Inc.
Small Acquisition(L)Direct4 shares at avg. $260.69$1K - Mar 6, 2025COR
Cencora, Inc.
Award(A)Direct789 shares- - Nov 1, 2024COR
Cencora, Inc.
Award(A)Direct368 shares at avg. $234.27$86K - Aug 5, 2024RVMD
Revolution Medicines, Inc.
Award(A)DirectStock Option (Right to Buy)
26.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  RVMD Revolution Medicines, Inc. | Award(A) | 1,191 | - | $0 | Direct |
| Apr 16, 2026 |  KLRA Kailera Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 38,300 | - | - | Direct |
| Mar 5, 2026 |  COR Cencora, Inc. | Award(A) | 557 | $359.28 | $200,119 | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award(A) | 2,806 | - | - | Direct |
| Mar 11, 2025 | COR Cencora, Inc. | Small Acquisition(L) | 4 | $260.69 | $1,043 | Direct |
| Mar 6, 2025 | COR Cencora, Inc. | Award(A) | 789 | - | - | Direct |
| Nov 1, 2024 | COR Cencora, Inc. | Award(A) | 368 | $234.27 | $86,211 | Direct |
| Aug 5, 2024 | RVMD Revolution Medicines, Inc. | Award(A) Stock Option (Right to Buy) | 26,540 | - | - | Direct |
1-8 of 8 transactions
About Clyburn Frank
Clyburn Frank (SEC CIK 0001763963) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD), Director of Kailera Therapeutics, Inc. (KLRA) and Director of Cencora, Inc. (COR).
Signal8 holds 10 ownership filings by Clyburn Frank (2 Form 3, 7 Form 4, 1 Form 5), filed between Oct 1, 2024 and Jun 23, 2026. Those filings report 8 transactions, from Aug 5, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Clyburn Frank's filings is in CONSHOHOCKEN, PA.
Recent filings by Clyburn Frank
- Jun 18, 2026: Grant or award of RVMD shares (Form 4, code A).
- Apr 16, 2026: Grant or award of KLRA derivative securities (Form 4, code A).
- Mar 5, 2026: Grant or award of COR shares (Form 4, code A).
- Jun 26, 2025: Grant or award of RVMD shares (Form 4, code A).
- Mar 11, 2025: Small acquisition transaction of COR shares (Form 5, code L).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer